Antidepressants and Advertising: Psychopharmaceuticals in Crisis

Kermit Cole
4
150

An article by written by faculty of the Harvard History of Science Department and the Program in Placebo Studies explores how “drug marketing portrays idealized scientific relationships between psychopharmaceuticals and depression … and how the placebo effect has become a critical issue in these debates, including the possible role of drug advertising to influence the placebo effect directly.” The article appears in the Yale Journal of Biology and Medicine.

Article → 

Previous articlePlaying Hide-and-Seek with Psychiatric Drug Studies
Next articleChildhood Adversity Increases Psychosis
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]

4 COMMENTS